Pia Michel

Head of Science Translation at Prima Materia

Head of Science Translation
2021 - Current
We are a European company that builds and develops new companies for the long term. Through our companies, we leverage technology to drive progress in areas that matter most to society.

Associate
2019 - 2021
Deal sourcing, research and due diligence for early stage investments at the intersection of nature and technology. BlueYard backs founders at the earliest stages building the interconnected elements that can become the fabric of our future.

Analyst
2018 - 2019
I worked on technology research and investment analyses for early stage investments in new business areas for Merck like synthetic biology, neuro technology and cell grown meat. M Ventures focuses on identifying and financing novel solutions to some of the most difficult challenges, through company creation and equity investments in fields that will impact the vitality and sustainability of Merck’s current and future businesses.